NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
63323-103-65 | 63323-103 | HUMAN PRESCRIPTION DRUG | Cisplatin | CISPLATIN | INJECTION, SOLUTION | INTRAVENOUS | 20000905 | N/A | ANDA | ANDA074735 | Fresenius Kabi USA, LLC | CISPLATIN | 1 mg/mL | 1 VIAL in 1 CARTON (63323-103-65) / 100 mL in 1 VIAL |
63323-103-64 | 63323-103 | HUMAN PRESCRIPTION DRUG | Cisplatin | CISPLATIN | INJECTION, SOLUTION | INTRAVENOUS | 20000905 | N/A | ANDA | ANDA074735 | Fresenius Kabi USA, LLC | CISPLATIN | 1 mg/mL | 1 VIAL in 1 CARTON (63323-103-64) / 200 mL in 1 VIAL |
63323-103-51 | 63323-103 | HUMAN PRESCRIPTION DRUG | Cisplatin | CISPLATIN | INJECTION, SOLUTION | INTRAVENOUS | 20000905 | N/A | ANDA | ANDA074735 | Fresenius Kabi USA, LLC | CISPLATIN | 1 mg/mL | 1 VIAL in 1 CARTON (63323-103-51) / 50 mL in 1 VIAL |